1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Medical Cannabis Treatment 1.2.3 Capsaicin-derived Treatment 1.2.4 Menthol-containing Treatment 1.2.5 Omega 3 fatty acid-containing Treatment 1.2.6 Botulinum Toxins 1.3 Market by Application 1.3.1 Global Non-Opioid Pain Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Orthopaedic and Musculoskeletal Pain 1.3.3 Neuropathic Pain 1.3.4 Cancer Pain 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Non-Opioid Pain Treatment Market Perspective (2016-2027) 2.2 Non-Opioid Pain Treatment Growth Trends by Regions 2.2.1 Non-Opioid Pain Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Non-Opioid Pain Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Non-Opioid Pain Treatment Industry Dynamic 2.3.1 Non-Opioid Pain Treatment Market Trends 2.3.2 Non-Opioid Pain Treatment Market Drivers 2.3.3 Non-Opioid Pain Treatment Market Challenges 2.3.4 Non-Opioid Pain Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Non-Opioid Pain Treatment Players by Revenue 3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2016-2021) 3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue 3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio 3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2020 3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served 3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service 3.7 Date of Enter into Non-Opioid Pain Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Non-Opioid Pain Treatment Breakdown Data by Type 4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2016-2021) 4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2022-2027) 5 Non-Opioid Pain Treatment Breakdown Data by Application 5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2016-2021) 5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Non-Opioid Pain Treatment Market Size (2016-2027) 6.2 North America Non-Opioid Pain Treatment Market Size by Type 6.2.1 North America Non-Opioid Pain Treatment Market Size by Type (2016-2021) 6.2.2 North America Non-Opioid Pain Treatment Market Size by Type (2022-2027) 6.2.3 North America Non-Opioid Pain Treatment Market Size by Type (2016-2027) 6.3 North America Non-Opioid Pain Treatment Market Size by Application 6.3.1 North America Non-Opioid Pain Treatment Market Size by Application (2016-2021) 6.3.2 North America Non-Opioid Pain Treatment Market Size by Application (2022-2027) 6.3.3 North America Non-Opioid Pain Treatment Market Size by Application (2016-2027) 6.4 North America Non-Opioid Pain Treatment Market Size by Country 6.4.1 North America Non-Opioid Pain Treatment Market Size by Country (2016-2021) 6.4.2 North America Non-Opioid Pain Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Non-Opioid Pain Treatment Market Size (2016-2027) 7.2 Europe Non-Opioid Pain Treatment Market Size by Type 7.2.1 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2021) 7.2.2 Europe Non-Opioid Pain Treatment Market Size by Type (2022-2027) 7.2.3 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2027) 7.3 Europe Non-Opioid Pain Treatment Market Size by Application 7.3.1 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2021) 7.3.2 Europe Non-Opioid Pain Treatment Market Size by Application (2022-2027) 7.3.3 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2027) 7.4 Europe Non-Opioid Pain Treatment Market Size by Country 7.4.1 Europe Non-Opioid Pain Treatment Market Size by Country (2016-2021) 7.4.2 Europe Non-Opioid Pain Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2016-2027) 8.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type 8.2.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application 8.3.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region 8.4.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Non-Opioid Pain Treatment Market Size (2016-2027) 9.2 Latin America Non-Opioid Pain Treatment Market Size by Type 9.2.1 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Non-Opioid Pain Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2027) 9.3 Latin America Non-Opioid Pain Treatment Market Size by Application 9.3.1 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Non-Opioid Pain Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2027) 9.4 Latin America Non-Opioid Pain Treatment Market Size by Country 9.4.1 Latin America Non-Opioid Pain Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Non-Opioid Pain Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2016-2027) 10.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type 10.2.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application 10.3.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country 10.4.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan PLC 11.1.1 Allergan PLC Company Details 11.1.2 Allergan PLC Business Overview 11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction 11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.1.5 Allergan PLC Recent Development 11.2 Canopy Growth 11.2.1 Canopy Growth Company Details 11.2.2 Canopy Growth Business Overview 11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction 11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.2.5 Canopy Growth Recent Development 11.3 Medical Marijuana Inc. 11.3.1 Medical Marijuana Inc. Company Details 11.3.2 Medical Marijuana Inc. Business Overview 11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction 11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.3.5 Medical Marijuana Inc. Recent Development 11.4 Panag Pharma Inc. 11.4.1 Panag Pharma Inc. Company Details 11.4.2 Panag Pharma Inc. Business Overview 11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction 11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.4.5 Panag Pharma Inc. Recent Development 11.5 Tilray 11.5.1 Tilray Company Details 11.5.2 Tilray Business Overview 11.5.3 Tilray Non-Opioid Pain Treatment Introduction 11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.5.5 Tilray Recent Development 11.6 Aphria Inc. 11.6.1 Aphria Inc. Company Details 11.6.2 Aphria Inc. Business Overview 11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction 11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.6.5 Aphria Inc. Recent Development 11.7 Bedrocan 11.7.1 Bedrocan Company Details 11.7.2 Bedrocan Business Overview 11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction 11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.7.5 Bedrocan Recent Development 11.8 Cara Therapeutics 11.8.1 Cara Therapeutics Company Details 11.8.2 Cara Therapeutics Business Overview 11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction 11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.8.5 Cara Therapeutics Recent Development 11.9 Centrexion Therapeutics 11.9.1 Centrexion Therapeutics Company Details 11.9.2 Centrexion Therapeutics Business Overview 11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction 11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.9.5 Centrexion Therapeutics Recent Development 11.10 CHT Medical 11.10.1 CHT Medical Company Details 11.10.2 CHT Medical Business Overview 11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction 11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.10.5 CHT Medical Recent Development 11.11 Cronos Group 11.11.1 Cronos Group Company Details 11.11.2 Cronos Group Business Overview 11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction 11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.11.5 Cronos Group Recent Development 11.12 GW Pharmaceuticals 11.12.1 GW Pharmaceuticals Company Details 11.12.2 GW Pharmaceuticals Business Overview 11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction 11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.12.5 GW Pharmaceuticals Recent Development 11.13 Medropharm Gmbh 11.13.1 Medropharm Gmbh Company Details 11.13.2 Medropharm Gmbh Business Overview 11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction 11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.13.5 Medropharm Gmbh Recent Development 11.14 US Worldmeds LLC 11.14.1 US Worldmeds LLC Company Details 11.14.2 US Worldmeds LLC Business Overview 11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction 11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) 11.14.5 US Worldmeds LLC Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Medical Cannabis Treatment Table 3. Key Players of Capsaicin-derived Treatment Table 4. Key Players of Menthol-containing Treatment Table 5. Key Players of Omega 3 fatty acid-containing Treatment Table 6. Key Players of Botulinum Toxins Table 7. Global Non-Opioid Pain Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Non-Opioid Pain Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Non-Opioid Pain Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Non-Opioid Pain Treatment Market Share by Regions (2016-2021) Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Non-Opioid Pain Treatment Market Share by Regions (2022-2027) Table 13. Non-Opioid Pain Treatment Market Trends Table 14. Non-Opioid Pain Treatment Market Drivers Table 15. Non-Opioid Pain Treatment Market Challenges Table 16. Non-Opioid Pain Treatment Market Restraints Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Non-Opioid Pain Treatment Market Share by Players (2016-2021) Table 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2020) Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Non-Opioid Pain Treatment Product Solution and Service Table 24. Date of Enter into Non-Opioid Pain Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million) Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2016-2021) Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Non-Opioid Pain Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2016-2021) Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million) Table 35. North America Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million) Table 37. North America Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million) Table 64. Allergan PLC Company Details Table 65. Allergan PLC Business Overview Table 66. Allergan PLC Non-Opioid Pain Treatment Product Table 67. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 68. Allergan PLC Recent Development Table 69. Canopy Growth Company Details Table 70. Canopy Growth Business Overview Table 71. Canopy Growth Non-Opioid Pain Treatment Product Table 72. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 73. Canopy Growth Recent Development Table 74. Medical Marijuana Inc. Company Details Table 75. Medical Marijuana Inc. Business Overview Table 76. Medical Marijuana Inc. Non-Opioid Pain Treatment Product Table 77. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 78. Medical Marijuana Inc. Recent Development Table 79. Panag Pharma Inc. Company Details Table 80. Panag Pharma Inc. Business Overview Table 81. Panag Pharma Inc. Non-Opioid Pain Treatment Product Table 82. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 83. Panag Pharma Inc. Recent Development Table 84. Tilray Company Details Table 85. Tilray Business Overview Table 86. Tilray Non-Opioid Pain Treatment Product Table 87. Tilray Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 88. Tilray Recent Development Table 89. Aphria Inc. Company Details Table 90. Aphria Inc. Business Overview Table 91. Aphria Inc. Non-Opioid Pain Treatment Product Table 92. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 93. Aphria Inc. Recent Development Table 94. Bedrocan Company Details Table 95. Bedrocan Business Overview Table 96. Bedrocan Non-Opioid Pain Treatment Product Table 97. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 98. Bedrocan Recent Development Table 99. Cara Therapeutics Company Details Table 100. Cara Therapeutics Business Overview Table 101. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 102. Cara Therapeutics Recent Development Table 103. Centrexion Therapeutics Company Details Table 104. Centrexion Therapeutics Business Overview Table 105. Centrexion Therapeutics Non-Opioid Pain Treatment Product Table 106. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 107. Centrexion Therapeutics Recent Development Table 108. CHT Medical Company Details Table 109. CHT Medical Business Overview Table 110. CHT Medical Non-Opioid Pain Treatment Product Table 111. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 112. CHT Medical Recent Development Table 113. Cronos Group Company Details Table 114. Cronos Group Business Overview Table 115. Cronos Group Non-Opioid Pain Treatment Product Table 116. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 117. Cronos Group Recent Development Table 118. GW Pharmaceuticals Company Details Table 119. GW Pharmaceuticals Business Overview Table 120. GW Pharmaceuticals Non-Opioid Pain Treatment Product Table 121. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 122. GW Pharmaceuticals Recent Development Table 123. Medropharm Gmbh Company Details Table 124. Medropharm Gmbh Business Overview Table 125. Medropharm Gmbh Non-Opioid Pain Treatment Product Table 126. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 127. Medropharm Gmbh Recent Development Table 128. US Worldmeds LLC Company Details Table 129. US Worldmeds LLC Business Overview Table 130. US Worldmeds LLC Non-Opioid Pain Treatment Product Table 131. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million) Table 132. US Worldmeds LLC Recent Development Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Global Non-Opioid Pain Treatment Market Share by Type: 2020 VS 2027 Figure 2. Medical Cannabis Treatment Features Figure 3. Capsaicin-derived Treatment Features Figure 4. Menthol-containing Treatment Features Figure 5. Omega 3 fatty acid-containing Treatment Features Figure 6. Botulinum Toxins Features Figure 7. Global Non-Opioid Pain Treatment Market Share by Application: 2020 VS 2027 Figure 8. Orthopaedic and Musculoskeletal Pain Case Studies Figure 9. Neuropathic Pain Case Studies Figure 10. Cancer Pain Case Studies Figure 11. Others Case Studies Figure 12. Non-Opioid Pain Treatment Report Years Considered Figure 13. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Non-Opioid Pain Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Non-Opioid Pain Treatment Market Share by Regions: 2020 VS 2027 Figure 16. Global Non-Opioid Pain Treatment Market Share by Regions (2022-2027) Figure 17. Global Non-Opioid Pain Treatment Market Share by Players in 2020 Figure 18. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2020 Figure 20. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2016-2021) Figure 21. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2022-2027) Figure 22. North America Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Non-Opioid Pain Treatment Market Share by Type (2016-2027) Figure 24. North America Non-Opioid Pain Treatment Market Share by Application (2016-2027) Figure 25. North America Non-Opioid Pain Treatment Market Share by Country (2016-2027) Figure 26. United States Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Non-Opioid Pain Treatment Market Share by Type (2016-2027) Figure 30. Europe Non-Opioid Pain Treatment Market Share by Application (2016-2027) Figure 31. Europe Non-Opioid Pain Treatment Market Share by Country (2016-2027) Figure 32. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Non-Opioid Pain Treatment Market Share by Type (2016-2027) Figure 40. Asia-Pacific Non-Opioid Pain Treatment Market Share by Application (2016-2027) Figure 41. Asia-Pacific Non-Opioid Pain Treatment Market Share by Region (2016-2027) Figure 42. China Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Non-Opioid Pain Treatment Market Share by Type (2016-2027) Figure 50. Latin America Non-Opioid Pain Treatment Market Share by Application (2016-2027) Figure 51. Latin America Non-Opioid Pain Treatment Market Share by Country (2016-2027) Figure 52. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Non-Opioid Pain Treatment Market Share by Type (2016-2027) Figure 56. Middle East & Africa Non-Opioid Pain Treatment Market Share by Application (2016-2027) Figure 57. Middle East & Africa Non-Opioid Pain Treatment Market Share by Country (2016-2027) Figure 58. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 62. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 63. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 64. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 65. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 66. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 67. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 68. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 69. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 70. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 71. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 72. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 73. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 74. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

Allergan PLC Canopy Growth Medical Marijuana Inc. Panag Pharma Inc. Tilray Aphria Inc. Bedrocan Cara Therapeutics Centrexion Therapeutics CHT Medical Cronos Group GW Pharmaceuticals Medropharm Gmbh US Worldmeds LLC